- Investing Ideas
- /
- Bulgarian Pharmaceuticals & Biotech Potentially Undervalued Companies
Bulgarian Pharmaceuticals & Biotech Potentially Undervalued Companies
UPDATED May 26, 2024
Companies with a Value score of at least 3, ordered by Value score
15 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
21P | CA$6.27 | -6.4% | 21.6% | CA$495.3m | CA$6.68 | PE1.2x | E-52.1% | n/a | ||
JNJ | US$140.64 | 1.4% | n/a | US$353.7b | US$165.08 | PE20.7x | E6.9% | 3.4% | ||
BAYN | €28.32 | 5.9% | -47.1% | €27.1b | €37.83 | PB0.8x | E49.1% | 0.4% | ||
TEV | US$9.38 | 0% | 11.7% | US$11.0b | US$10.55 | PB1.6x | E64.8% | 0% | ||
EVT | €10.09 | 0% | n/a | €1.6b | €23.72 | PS2x | E60.4% | n/a | ||
NVV1 | US$12.05 | 0% | n/a | US$2.2b | US$16.79 | PS2.2x | E64.3% | n/a | ||
PFE | US$26.50 | 0% | -25.0% | US$163.7b | US$29.29 | PS3x | E30.6% | 5.8% | ||
6MK | US$89.50 | 0% | n/a | US$218.2b | US$103.93 | PE13.1x | E10.2% | 3.2% | ||
2HQ | US$1.67 | 0% | n/a | US$1.5b | US$2.14 | PS2.1x | E86.8% | n/a | ||
SNW | €87.98 | 0% | n/a | €116.2b | €102.14 | PE25.6x | E16.6% | 4.0% | ||
AM1 | US$286.08 | -1.1% | 41.8% | US$164.1b | US$295.83 | PE43.6x | E18.0% | 2.9% | ||
22UA | US$121.65 | 0% | -18.3% | US$34.8b | US$182.54 | PE3.1x | E-38.6% | n/a | ||
MRK | €154.20 | 0% | -7.1% | €72.0b | €181.91 | PE23.4x | E11.4% | 1.3% | ||
4AB | US$128.20 | 0% | n/a | US$255.5b | US$147.69 | PE29.6x | E11.3% | 4.1% | ||
ZEG | UK£120.75 | 0% | n/a | UK£191.7b | UK£129.29 | PE38.5x | E15.0% | 2.0% |
Page 1 of 1